Donanemab 350mg/20ml solution for infusion vials
- SNOMED code
44014311000001101- Active compound
- Donanemab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 20 ml, vial
- Ingredients
- Donanemab
— 17.5 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Kisunla 350mg/20ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd)
in short Kisunla 350mg/20ml concentrate for inf vials
Kisunla 350mg/20ml concentrate for solution for infusion vials
- SNOMED code
44012811000001104- Supplier
- Eli Lilly and Company Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- Restricted Availability
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Kisunla 350mg/20ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial44012911000001109 ref. pack | 💯 Available Legal category: POM | 5014602102012 | NHS Indicative Price £613.60 | • Hospital |
| — |
Reference packs
Donanemab 350mg/20ml solution for infusion vials 1 vial
- SNOMED code
44012711000001107- Quantity and unit
- 1 vial
- Packs